# Erector Spinae Block for Spine Surgery

> **NCT05417113** · PHASE4 · TERMINATED · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 13 (actual)

## Conditions studied

- Lumbar Radiculopathy

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT05417113
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-08-31
- **Primary completion:** 2024-02-27
- **Final completion:** 2024-02-27
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** recruitment difficulty
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05417113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05417113, "Erector Spinae Block for Spine Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05417113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*